Form 4 for CUE Cue Biopharma, Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001209191-22-022570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | F - Tax | $4.88 | -32.1K | 141.6K | -18% | -$156.8K |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | G - Gift | $0.00 | -10.0K | 131.6K | -7% | $0 |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 173.7K | +76% | — |
| D | 2022-04-04 | 2022-03-31 | CUE | PASSERI DANIEL R | CEO, Dir | M - OptEx | $0.00 | -75.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | F | D | 32,122 | $4.88 | 141,578 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-31 | G | D | 10,000 | $0.00 | 131,578 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-31 | M | A | 75,000 | — | 173,700 | D | — | — | (F1) Represents shares of common stock received upon vesting of a restricted stock unit award. |
| 4 | Derivative | Restricted Stock Units | 2022-03-31 | M | D | 75,000 | $0.00 | 0 | D | — · — to — | 75,000 Common Stock | (F2) Each restricted stock unit award represents a contingent right to receive one share of common stock. (F3) One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022. |